Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology consensus review on diagnosis, management, and future directions.

adolescents and young adults brain tumors precision medicine survivorship

Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
23 Oct 2024
Historique:
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 23 10 2024
Statut: aheadofprint

Résumé

Adolescents and young adults (AYAs; ages 15-39 years) are a vulnerable population facing challenges in oncological care, including access to specialized care, transition of care, unique tumor biology, and poor representation in clinical trials. Brain tumors are the second most common tumor type in AYA, with malignant brain tumors being the most common cause of cancer-related death. The 2021 WHO Classification for central nervous system (CNS) Tumors highlights the importance of integrated molecular characterization with histologic diagnosis in several tumors relevant to the AYA population. In this position paper from the Society for Neuro-Oncology (SNO), the diagnosis and management of CNS tumors in AYA is reviewed, focusing on the most common tumor types in this population, namely glioma, medulloblastoma, ependymoma, and CNS germ cell tumor. Current challenges and future directions specific to AYA are also highlighted. Finally, possible solutions to address barriers in the care of AYA patients are discussed, emphasizing the need for multidisciplinary and collaborative approaches that span the pediatric and adult paradigms of care, and incorporating advanced molecular testing, targeted therapy, and AYA-centered care.

Identifiants

pubmed: 39441704
pii: 7833318
doi: 10.1093/neuonc/noae186
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Mary Jane Lim-Fat (MJ)

Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.

Julie Bennett (J)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Quinn Ostrom (Q)

The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina, USA.
Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.

Mehdi Touat (M)

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-oncologie, Paris, France.
Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Enrico Franceschi (E)

Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna / AUSL di Bologna, Bologna, Italy.

Jessica Schulte (J)

Neurosciences Department, University of California San Diego, La Jolla, California, USA.

Ranjit S Bindra (RS)

Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA.

Jason Fangusaro (J)

Children's Healthcare of Atlanta, Emory University, and the Aflac Cancer Center, Atlanta, Georgia, USA.

Girish Dhall (G)

Department of Hematology and Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA.

James Nicholson (J)

Paediatric Oncology, Cambridge University Hospitals and Department of Paediatrics, Cambridge University, UK.

Sadhana Jackson (S)

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.

Tom Belle Davidson (TB)

Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Gabriele Calaminus (G)

Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany.

Giles Robinson (G)

Department of Oncology, Neurobiology and Brain Tumor Program, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

James R Whittle (JR)

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Personalised Oncology Division, WEHI, Parkville, Victoria, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.

Peter Hau (P)

Department of Neurology and Wilhelm Sander-Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany.

Vijay Ramaswamy (V)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kristian W Pajtler (KW)

Hopp Children's Cancer Center Heidelberg (KiTZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Division of Pediatric Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Roberta Rudà (R)

Division of Neuro-Oncology, Department Neuroscience Rita Levi Montalcini, University of Turin and City of Health and Science University Hospital, Turin, Italy.

Nicholas K Foreman (NK)

Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.

Shawn L Hervey-Jumper (SL)

Department of Neurological Surgery, University of California, San Francisco, California, USA.

Sunit Das (S)

Division of Neurosurgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Peter Dirks (P)

Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada.

Wenya Linda Bi (WL)

Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Annie Huang (A)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Thomas E Merchant (TE)

Department of Radiation Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Maryam Fouladi (M)

Division of Hematology/Oncology, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Kenneth Aldape (K)

Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA.

Martin J Van den Bent (MJ)

The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Roger J Packer (RJ)

Brain Tumor Institute, Gilbert Family Neurofibromatosis Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, District of Columbia, USA.

Julie J Miller (JJ)

Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

David A Reardon (DA)

Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

Susan M Chang (SM)

Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, California, USA.

Daphne Haas-Kogan (D)

Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.

Uri Tabori (U)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Cynthia Hawkins (C)

Department of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Michelle Monje (M)

Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.

Patrick Y Wen (PY)

Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

Eric Bouffet (E)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kee Kiat Yeo (KK)

Department of Pediatric Oncology, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.

Classifications MeSH